Sources
1. ASHP Guidelines on Handling Hazardous Drugs, American Journal of Health-System Pharmacy, Volume 63, Issue 12, 15 June 2006, Pages 1172–1191,
https://doi.org/10.2146/ajhp050529
2. ASTM D6978-05(2019), Standard Practice for Assessment of Resistance of Medical Gloves to Permeation by Chemotherapy Drugs, ASTM International, West Conshohocken, PA, 2019.
3. Connor, T.H. and McDiarmid, M.A. (2006), Preventing Occupational Exposures to Antineoplastic Drugs in Health Care Settings. CA: A Cancer Journal for Clinicians, 56: 354-365.
https://doi.org/10.3322/canjclin.56.6.354
4. Connor, T. H., Anderson, R. W., Sessink, P. J., Broadfield, L., & Power, L. A. (1999). Surface contamination with antineoplastic agents in six cancer treatment centers in Canada and the United States. American journal of health-system pharmacy: AJHP : official journal of the American Society of Health-System Pharmacists, 56(14), 1427–1432.
https://doi.org/10.1093/ajhp/56.14.1427
5. Connor, T.H., Anderson, R.W., Sessink, P.J., & Spivey, S.M. (2002). Effectiveness of a closed-system device in containing surface contamination with cyclophosphamide and ifosfamide in an i.v. admixture area. American Journal of Health System Pharmacy, 59, 68-72.
6. Connor, T. H., DeBord, D. G., Pretty, J. R., Oliver, M. S., Roth, T. S., Lees, P. S., Krieg, E. F., Jr, Rogers, B., Escalante, C. P., Toennis, C. A., Clark, J. C., Johnson, B. C., & McDiarmid, M. A. (2010). Evaluation of antineoplastic drug exposure of health care workers at three university-based US cancer centers. Journal of occupational and environmental medicine, 52(10), 1019–1027.
https://doi.org/10.1097/JOM.0b013e3181f72b63.
7. Friese, C. R., McArdle, C., Zhao, T., Sun, D., Spasojevic, I., Polovich, M., & McCullagh, M. C. (2015). Antineoplastic drug exposure in an ambulatory setting: a pilot study. Cancer Nursing, 38(2), 111–117.
https://doi.org/10.1097/NCC.0000000000000143.
8. Friese, C., Wong, M., Fauer, A., Mendelsohn-Victor, K., Polovich, M., & McCullagh, M. (2020). Hazardous Drug Exposure: Case Report Analysis From a Prospective, Multisite Study of Oncology Nurses’ Exposure in Ambulatory Settings. Clinical Journal of Oncology Nursing, 24(3), 249–255.
https://doi.org/10.1188/20.cjon.249-255
9. Hammond, Duane & Meda, Kenneth. Preventing Exposure to Hazardous Drugs: Engineering-Control Recommendations in the NIOSH Alert. Pharmacy Purchasing & Products.
10. NIOSH. National Institute for Occupational Safety and Health list of antineoplastic and other hazardous drugs in health-care settings (2016). US Department of Health and Human Services, Centers for Disease NIOSH. National Institute for Occupational Safety and Health. (2020, May 4). Hazardous Drug Exposures in Health Care. Centers for Disease Control and Prevention, National Institute for
Occupational Safety and Health,
https://www.cdc.gov/niosh/topics/hazdrug/default.html
12. Occupational Safety and Health Administration (OHSA). Hazardous Drugs - Controlling Occupational Exposure to Hazardous Drugs, Chapter VI, Section 3.
13. Power, L. A., & Coyne, J. W. (2018). ASHP Guidelines on Handling Hazardous Drugs. American journal of health-system pharmacy: AJHP : official journal of the American Society of Health-System Pharmacists, 75(24), 1996–2031.
https://doi.org/10.2146/ajhp180564.
14. Sessink, P. J., Connor, T. H., Jorgenson, J. A., & Tyler, T. G. (2011). Reduction in surface contamination with antineoplastic drugs in 22 hospital pharmacies in the US following implementation of a closed-system drug transfer device. Journal of oncology pharmacy practice: official publication of the International Society of Oncology Pharmacy Practitioners, 17(1), 39–48.
https://doi.org/10.1177/1078155210361431.
15. Siderov, J., Kirsa, S., & McLauchlan, R. (2010). Reducing workplace cytotoxic surface contamination using a closed-system drug transfer device. Journal of Oncology Pharmacy Practice, 16(1), 19–25.
https://doi.org/10.1177/1078155209352543
17. The United States Pharmacopeial Convention. USP<797> Guidebook to pharmaceutical compounding – sterile preparations. In: The United States Pharmacopeial Convention, Rockville, MD, 2008.
19. Wallemacq, Ph.D., Pierre E., Capron, M.Sc., Arnaud, Vanbinst, M.Sc., Roger, Boeckmans, Eric, Gillard, Ph.D., Jean, Favier, Pharm.D., Bertrand, Permeability of 13 different gloves to 13 cytotoxic agents under controlled dynamic conditions, American Journal of Health-System Pharmacy, Volume 63, Issue 6, 15 March 2006, Pages 547–556,
https://doi.org/10.2146/ajhp050197.